Topics
July/August 2016 | What's New On The Anti-pdgf Front?
An Oral Drug for Treatment of AMD?
The potential for this proposed treatment option could be significant for many patients and their caregivers.
Carl C. Awh, MD
August 10, 2026
Oculis to Acquire Global Rights to Privosegtor from Accure Therapeutics
August 7, 2026
UK Study Finds Ophthalmic Clinical Letters Increasingly Difficult for Patients to Read
August 6, 2026
Norlase Expands European Footprint with Direct Sales Model in Germany
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals
July/August 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
July/August 2026 Supplement
Editorially Independent Content, Supported With Advertising From Astellas
Editorially Independent Content, Supported With Advertising From Astellas and ZEISS
July 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
_1784132761.jpg?auto=compress,format&w=70)
